Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.

Conditions:   Glioblastoma;   Molecular Disease Intervention:   Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA Sponsor:   Centre Hospitalier Universitaire, Amiens Recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials